Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$5.95 - $14.3 $2.95 Million - $7.09 Million
-495,565 Reduced 48.6%
524,059 $3.23 Million
Q2 2022

Aug 10, 2022

SELL
$10.6 - $13.28 $4.12 Million - $5.17 Million
-388,964 Reduced 27.61%
1,019,624 $12.1 Million
Q1 2021

May 13, 2021

BUY
$15.15 - $19.78 $21.3 Million - $27.9 Million
1,408,588 New
1,408,588 $24.4 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Soditic Asset Management LLP Portfolio

Follow Soditic Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soditic Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Soditic Asset Management LLP with notifications on news.